{
    "DAS remission (follow up: 1 year; assessed with DAS44 ≤ 1.6)": {
        "No of studies": "1",
        "Study design": "observational studies",
        "Risk of bias": [
            "not serious",
            "a",
            "b"
        ],
        "Inconsistency": "not serious",
        "Indirectness": "not serious",
        "Imprecision": "not serious",
        "Other considerations": "none",
        "Nº of patients": {
            "a treatment goal of low disease activity": "40/133 (30.1%)",
            "a treatment goal of remission": "89/175 (50.9%)"
        },
        "Effect": {
            "Relative (95% CI)": "RR 0.59 (0.44 to 0.80)",
            "Absolute (95% CI)": "209 fewer per 1,000 (from 285 fewer to 102 fewer)"
        },
        "Certainty": "⨁⨁◯◯ LOW",
        "Importance": "CRITICAL"
    },
    "Disease activity (follow up: 1 year; assessed with DAS-44 (Lower values – > benefit) (MCID -1.2)": {
        "No of studies": "1",
        "Study design": "observational studies",
        "Risk of bias": [
            "not serious",
            "a"
        ],
        "Inconsistency": "not serious",
        "Indirectness": "not serious",
        "Imprecision": "not serious",
        "Other considerations": "none",
        "Nº of patients": {
            "a treatment goal of low disease activity": "133",
            "a treatment goal of remission": "175"
        },
        "Effect": {
            "Relative (95% CI)": "-",
            "Absolute (95% CI)": "MD 0.1 lower (0.35 lower to 0.15 higher)"
        },
        "Certainty": "⨁⨁◯◯ LOW",
        "Importance": "CRITICAL"
    }
}